TABLE 4.
Costs of Nonindicated Screening and Follow-Up Tests in Women After Hysterectomy (n = 605)
| Screening result | n (%) | Diagnostic test costs, US | Follow-up test costs, US |
|---|---|---|---|
| Initial screening | 605 | $55,660 | NA |
| ASC-H | 1 (0.2) | $525a | $420 |
| LSIL, hrHPV− | 4 (0.7) | $192b | $1,120 |
| LSIL, hrHPV+ | 3 (0.5) | $1,719c | $1,260 |
| LSIL, hrHPV NOS | 5 (0.8) | $2,625d | $2,100 |
| ASCUS, hrHPV− | 19(3.1) | $912b | $2,660 |
| ASCUS, hrHPV+ | 7(1.2) | $4,011c | $2,940 |
| Unsatisfactory | 13 (2.1) | $1,196e | NA |
| Total cost: US $77,340 for 5 y | |||
a
Cost of colposcopy + 1 biopsy. bCost for reflex hrHPV testing.
b
Cost for reflex hrHPV testing.
c
Cost for reflex hrHPV testing + colposcopy + 1 biopsy.
d
Cost for colposcopy + 1 biopsy.
e
Cost of repeat screening Pap test.
ASC-H indicates atypical squamous cells, cannot rule-out high-grade; ASCUS, atypical squamous cells of undetermined significance; hrHPV, high-risk human papillomavirus; LSIL, low-grade squamous intraepithelial lesion; NA, not available; NOS, not done.